Elevation Oncology, Inc.
ELEV
$0.381
-$0.0039-1.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.21M | -10.44M | -12.88M | -10.46M | -10.71M |
| Total Depreciation and Amortization | 5.00K | 5.00K | 5.00K | 4.00K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 853.00K | 904.00K | 820.00K | 807.00K | 1.73M |
| Change in Net Operating Assets | 642.00K | -675.00K | 3.67M | 1.45M | -605.00K |
| Cash from Operations | -12.71M | -10.20M | -8.38M | -8.21M | -9.58M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.76M | 11.47M | -2.87M | -37.66M | 20.70M |
| Cash from Investing | 23.76M | 11.47M | -2.87M | -37.66M | 20.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 12.00K | 14.72M | 30.43M |
| Repurchase of Common Stock | -17.00K | -4.00K | -2.00K | -16.00K | -26.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -20.00K | -150.00K |
| Cash from Financing | -17.00K | -4.00K | 10.00K | 14.68M | 30.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.03M | 1.26M | -11.25M | -31.18M | 41.38M |